Patents by Inventor Joseph MANDELBAUM

Joseph MANDELBAUM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200362308
    Abstract: Described herein are methods for inducing HSC specification in a cell. Aspects of the invention relate to contacting a cell with a Runx1-CBF? inhibitor for a specified period of time, and then removing the inhibitor from the cell. In some embodiments of any of the aspects, HSC specificity is maintained long-term.
    Type: Application
    Filed: August 21, 2018
    Publication date: November 19, 2020
    Applicant: THE CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Leonard I. ZON, Joseph MANDELBAUM
  • Patent number: 10668039
    Abstract: The present invention is directed to compositions and methods for treating Adenoid Cystic Carcinoma (ACC).
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: June 2, 2020
    Assignee: THE CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Leonard I. Zon, Joseph Mandelbaum
  • Publication number: 20190192468
    Abstract: The present invention is directed to compositions and methods for treating Adenoid Cystic Carcinoma (ACC).
    Type: Application
    Filed: September 1, 2017
    Publication date: June 27, 2019
    Inventors: Leonard I. ZON, Joseph MANDELBAUM